Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-24 @ 9:28 PM
NCT ID:
NCT05728632
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years
* Established histologic diagnosis of breast cancer or diffuse large B-cell lymphoma
* Planned chemotherapy with anthracyclines
* left ventricular ejection fraction ≥55% (assessed by echocardiography)
* Ability to provide informed consent
Exclusion Criteria:
* Known intolerance/contraindications to betablocker therapy
* History of coronary artery disease
* History of cardiomyopathy
* History of heart failure
* Ongoing treatment with betablockers for other indications
* Heart rate at baseline \<60 beats per minute
* Arterial blood pressure at baseline \<100/60 mmHg
* Contraindications to undergo cardiac magnetic resonance (e.g., non-compatible pacemakers or metallic prosthesis)
* Pregnancy or lactation
* Current participation to another study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05728632
Study Brief:
Protocol Section:
NCT05728632